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OBJECTIVE — To describe 25-hydroxy vitamin D (25-OH-D) levels and examine associa-
tions between 25-OH-D levels and insulin resistance (IR), metabolic syndrome (MS), and glu-
cose intolerance in Arab Americans.
RESEARCH DESIGN AND METHODS — Serum 25-OH-D levels were measured in a
representative, cross-sectional sample of 542 Arab Americans with IR (46%), MS (33%), and
glucose intolerance (42%).
RESULTS — VitaminDinsufﬁciency(5to20ng/ml)waspresentin75%andhypovitamin-
osis D (20 to 40 ng/ml) in 24% of participants. In men, 25-OH-D levels were lower in those
with glucose intolerance than normoglycemia (P  0.01). No such difference was found in
women. In men, 25-OH-D was negatively correlated with homeostasis model assessment of
insulin resistance (r  0.19; P  0.0043), triglycerides (r  0.18; P  0.0069), fasting
plasmaglucose(r0.15;P0.027),andA1C(r0.14;P0.038).Inwomen,25-OH-D
was positively correlated with HDL (r  0.19; P  0.0008).
CONCLUSIONS — Vitamin D insufﬁciency and hypovitaminosis D are extremely common
among Arab Americans, and they are associated with IR, components of the MS, and glucose
intolerance in men.
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A
ltered calcium and vitamin D ho-
meostasis are associated with insu-
lin resistance (IR), reduced -cell
function, metabolic syndrome (MS), glu-
cose intolerance, and diabetes (1–4). We
have previously shown that the age- and
sex-standardizedprevalenceofdiabetesis
18% among Arab Americans (5–6). Al-
though previous studies have docu-
mented an association between 25-
hydroxy vitamin D (25-OH-D) levels and
glucose intolerance, few have focused on
the Arab American community, a cultur-
ally unique, under-studied, and medi-
cally underserved community in which
traditional dress may limit sun exposure
and dietary preferences may further con-
tribute to 25-OH-D deﬁciency. The pur-
poseofthisstudywastodescribelevelsof
25-OH-D and examine associations be-
tween 25-OH-D levels and IR, MS, and
glucose intolerance among Arab Ameri-
can adults.
RESEARCH DESIGN AND
METHODS— The methods have
been described in detail elsewhere (5–7).
Brieﬂy,westudied542randomlyselected
Arab Americans 20–75 years of age. De-
mographic, anthropometric, and behav-
ioral characteristics were measured. To
examine food preferences, we calculated
the ratio of Arab meals to total meals con-
sumed in 1 week; a higher ratio indicates
consumption of more Middle Eastern
foods (diet rich in meat, yogurt, grains,
and vegetables, and low in food fortiﬁed
withvitaminDsuchasmilkandbreakfast
cereals). Subjects performed strenuous
physical activity if they engaged in exer-
cise for 20 min that made them breathe
hardandsweat3timesperweek.Those
engaging in strenuous activity 3 times
weekly performed moderate physical ac-
tivityandallotherswereconsideredinac-
tive. Smoking status was self-reported
and veriﬁed by serum cotinine (Siemens
Healthcare Diagnostics, Deerﬁeld, IL).
Acculturation was assessed with a vali-
dated four-item survey.
Fasting glucose, insulin, lipids, and
A1C were measured and glucose
tolerance assessed with 75-g oral glucose
tolerance tests. IR was deﬁned as ho-
meostasis model assessment of insulin re-
sistance 3.8 (8). Subjects meeting the
revised National Cholesterol Education
Program Adult Treatment Panel III crite-
ria were deﬁned as having MS (9). Glu-
cose intolerance was deﬁned as impaired
fasting glucose, impaired glucose toler-
ance, or diabetes (10).
Serum 25-OH-D samples were
coded, centrifuged, and stored at 70°C.
In 2009, serum 25-OH-D was measured
using the
125I Radioimmunoassay kit
(DiaSorin, Stillwater, MN) and quality
control materials provided by the manu-
facturer. The inter-assay coefﬁcients of
variation are 7.3% at 13.7 ng/ml and
9.6% at 53.4 ng/ml. 25-OH-D status was
classiﬁed as: deﬁciency, 5 ng/ml; insuf-
ﬁciency, 5 to 20 ng/ml; hypovitamino-
sis D, 20 to 40 ng/ml; sufﬁciency, 40 to
100 ng/ml; and toxicity, 100 ng/ml
(11).
All analyses were performed sepa-
rately by sex. Data are expressed as
means  SD or percentage. Continuous
orcategoricaldatawereanalyzedutilizing
ANOVA or 
2 tests. 25-OH-D levels were
describedbydemographic,anthropomet-
ric,behavioralcharacteristicsandbymea-
sures of disease status. Spearman
correlation coefﬁcients were calculated to
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tus. Analyses were performed using SAS,
version 9.1 (SAS Institute, Cary, NC).
RESULTS— The mean age of the sub-
jects was 38  13 years and 39% were
men. The mean BMI was 28.4  5.5 kg/
m
2.Subjectsconsumedmostlytraditional
Middle Eastern foods. The majority of the
subjects were inactive or only moderately











Sample size 103 111 214 204 113 317
All 19.4  7.0 16.9  5.5 0.005 18.1  6.4 14.1  7.6 14.0  6.2 0.95 14.1  7.1
Age (years)* 0.94 0.92
20–29 20.1  6.2 16.1  4.5 18.6  5.9 13.8  6.8 15.7  9.5 14.0  7.1
30–39 19.3  8 16.8  7 18.3  7.7 15  9.3 13.2  5.9 14.8  8.9
40–49 20.6  7.2 16.8  5.2 18.2  6.2 13.8  7.3 11.9  3.5 13.1  6.2
50–59 17.5  5.7 17.4  5.9 17.4  5.7 12.5  4.3 15.2  7 14.3  6.3
60 17.6  5.1 17.4  4.7 17.5  4.7 13.2  4.3 14.4  6.1 14.1  5.7
BMI (kg/m
2)* 0.31 0.16
30 19.1  7.2 17.6  5.9 18.4  6.6 14.3  8.5 16.3  6.8 14.8  8.1
30 to 35 20.8  6.3 15.9  4.5 18  5.8 12.8  5 12.7  5.5 12.8  5.2
35 18.8  8.2 13.3  4.1 15.8  6.7 14.2  5.2 12.9  5.7 13.4  5.5
Food preference†* 0.15 0.50
0.5 20.7  6.1 § 21.6  6.3 18.6  7.6 § 18  7.4
0.5 to 0.8 18.7  6.5 16.5  6 17.9  6.4 15.1  7.3 13.7  5.2 14.6  6.7
0.8† 18.1  6.2 16.7  5.5 17.2  5.8 12.8  5.9 13.9  5.9 13.2  5.9
Physical activity* 0.22 0.98
Strenuous/moderate 19.7  7.6 17.5  5.3 18.6  6.6 14.6  9.2 14.1  7.2 14.4  8.6
Light/inactive 19  6.2 16.1  5.8 17.4  6.1 13.7  6 14.2  5.6 13.8  5.8
Smoking status* 0.44 0.27
Current smoker 18.6  6.3 16.6  5.6 17.7  6.1 14.5  7.5 12.9  4.8 14  6.9
Former smoker 19.9  6.4 17.9  3.3 18.7  4.7 17.5  7.5 15.3  5.3 16.5  6.5
Never smoker 20.4  7.9 16.9  6 18.4  7 13.7  7.6 14.3  6.7 13.9  7.2
Cotinine Status‡* 0.04 0.78
10 20.2  7.5 16.8  5.6 18.2  6.7 14.2  7.7 14  5.9 14.1  7.1
10–99 21.3  6.2 19.6  4.9 20.5  5.6 12.7  3.8 12.2  3 12.6  3.6
100–199 17.3  6.5 16.9  7.1 17.1  6.5 12  6 15.2  9 12.7  6.8
200–299 20.9  7.6 16.8  4.2 19.5  6.9 17.9  11 13.3  7.1 16.9  11
300† 15.3  4.2 15.7  5.5 15.5  4.8 14.5  4.9 15.6  8.8 15  6.7
Acculturation* 0.52 0.50
2 18.3  5.9 17.1  5.6 17.6  5.7 13.8  7.3 14  6.1 13.9  6.9
2† 23  9.2 15.4  5.5 20.8  9 15.2  8.7 14.9  7.7 15.2  8.4
Season* 0.0001 0.20
January–March 13.3  5.2 13.7  4.7 13.6  4.8 11.4  4.5 14.3  5.8 12.6  5.3
April–June 18.3  6.4 17.1  5.1 17.7  5.7 12.1  4.5 15.3  4.7 13  4.8
July–September 21.6  6.9 18.2  4.7 20  6.2 15  8.6 13  6.6 14.4  8.1
October–December 19.3  7 16.7  6.7 17.8  6.8 16.2  8.4 14.6  6.7 15.4  7.6
Normal Abnormal P Normal Abnormal P
HOMA-IR 19.4  6.9 16.9  5.7 0.01 14.8  8.2 13.1  5.2 0.1
Metabolic syndrome 18.5  6.6 17.1  5.8 0.16 14.9  7.9 12.6  5.1 0.0086
Waist circumference 18.3  6.5 17.4  5.9 0.45 15  8.4 13.1  5.3 0.093
Hypertension 18.1  6.7 18.3  5.8 0.62 14  7.3 14.3  6.8 0.56
Triglycerides 19.2  6.7 16.5  5.6 0.0016 14.3  7.4 13.4  6 0.37
HDL 18.4  6.7 17.8  6.1 0.52 15.4  8.4 12.9  5.4 0.0016
Fasting plasma
glucose 19.6  7 17.4  6 0.023 14.4  8 13.7  6.1 0.69
77 t o 99 † 77 t o 99 †
A1C 18.3  6.5 14.4  4.4 16.6  4.4 0.2 14  7.2 15.4  6.1 14.6  5 0.41
Data are mean  SD serum 25-OH-D levels expressed as ng/ml. *P value, of factor adjusted for glycemic status. †Ratio of Arabic meals to total meals consumed in
a1-weekperiodwithahigherratioindicatingconsumptionofmoreMiddleEasternfoods.‡Cotininelevels10ng/mlareconsideredtobeconsistentwithnoactive
smoking. §Insufﬁcient data. HOMA-IR, homeostasis model assessment of insulin resistance.
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ported smoking cigarettes. Acculturation
was low. IR was present in 46%, MS in
33%, and glucose intolerance in 42% of
subjects.
Vitamin D insufﬁciency was present
in 75% and hypovitaminosis D in 24%;
only four subjects had 25-OH-D levels in
the normal range. Serum 25-OH-D levels
were lower in women (14.1  7.1) than
men(18.16.4)(P0.0001).Onlytwo
subjects reported taking vitamin D
supplements.
Vitamin D levels as a function of glu-
cose tolerance status and other factors is
shown in Table 1. In men, 25-OH-D lev-
elswerelowerinthosewithglucoseintol-
erance than in those who were
normoglycemic(P0.005).Nosuchdif-
ference was found in women. 25-OH-D
levels also varied by season (P  0.0001)
and by level of cotinine (P  0.04) in
men. Men with IR, hypertriglyceridemia,
and glucose intolerance had lower serum
25-OH-D levels than men who were in-
sulin sensitive (P  0.01), had triglycer-
ides 150 mg/dl (P  0.0016), and
fasting plasma glucose 100 mg/dl (P 
0.023). Decreased 25-OH-D levels were
present in women with MS compared
with those without MS (P  0.0086).
Women with low HDL levels had low 25-
OH-D levels compared with those with
HDL levels 50 mg/dl (P  0.0016).
In men, serum 25-OH-D was nega-
tively correlated with homeostasis model
assessment of insulin resistance (r 
0.19; P  0.0043), triglycerides (r 
0.18; P  0.0069), fasting plasma glu-
cose (r  0.15; P  0.027), and A1C
(r  0.14; P  0.038). In women, 25-
OH-DwaspositivelycorrelatedwithHDL
(r  0.19; P  0.0008).
CONCLUSIONS — This study pro-
vides population-based estimates of vita-
min D status among Arab American and
reports associations between 25-OH-D
levels and IR, MS, and glucose intoler-
ance. Our ﬁndings are similar to those re-
ported from a convenience sample of 87
Arab American women and a representa-
tive sample of 6,228 people in the United
States (12–13) in whom vitamin D levels
were not adequate. 25-OH-D levels have
been inversely associated with diabetes in
non-Hispanic whites and Mexican Amer-
icans, but not in non-Hispanic blacks de-
spitetheirhighprevalenceofdiabetesand
inadequatevitaminDlevels(14–15).Our
ﬁndings in Arab American males are sim-
ilar to those reported in Hispanic whites
and Mexican Americans.
Thereareseveralpotentiallimitations
to our study. First, factors inﬂuencing
skin synthesis of vitamin D such as tradi-
tional Islamic dress, ultraviolet exposure,
andsunscreenutilizationanddietarycon-
sumption of vitamin D were not assessed.
Second, the cross-sectional design of our
study limited our ability to examine causal
relationships between levels of 25-OH-D
and IR, MS, and glucose intolerance.
In summary, the prevalence of inade-
quatevitaminDlevelsishighamongArab
Americanmenandwomen.Veryfewsub-
jects reported taking supplements. In
men, lower 25-OH-D levels were associ-
ated with IR, components of MS, and glu-
cose intolerance. In women, lower 25-
OH-D was associated with lower HDL
cholesterol levels. Greater public aware-
ness and interventions to encourage vita-
min D consumption are needed in the
Arab American community.
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